Vaccine-preventable diseases / Projects

3rd Health Programme (2014-2020)
EPHA Operating Grant Proposal 2016 SGA [EPHA SGA 2016]
The Annual Work Programme for 2016 of EPHA is drawn from the multiannual work programme 2015-2017 and builds on successes to date. EPHA’s activities in 2016 will continue to contribute to all four o...
The Annual Work Programme for 2016 of EPHA is drawn from the multiannual work programme 2015-2017 and builds on successes to date. EPHA’s activities in 2016 will continue to contribute to all four objectives of the Third Health Programme. EPHA has formally reviewed our Strategic Plan 2011-2015. We undertook a thorough consultation process involving Board members, Staff and the EPHA membership, and an analysis of EPHA’s operating environment, strengths and weaknesses. The EPHA membership formally approved the new Strategic Plan 2016-2020 at the Annual General Assembly on 4th September 2015. The Work Programme for 2016 reflects the revised strategy to define a clearer selection of priorities. This approach will enable EPHA to manage activities more effectively, encourage closer cooperation between members and across themes, and better monitor and evaluate our impact.EPHA’s overarching strategic objective remains: “To promote good health and wellbeing, to reduce disease and health inequalities in European policies and programmes”. Priorities selected are as follows:Under Aims 1 and 2 of the 3rdHP and EPHA Strategic Objective “Securing a Governance for Health Approach in Key EU Policies” (HiAP):- Agriculture and Food Policy including Alcohol, Tobacco and NCDs- EU Semester for Health- Healthy Trade Policy- Public Health and Research in the EU BudgetUnder Aims 3 and 4 of the 3rdHP and EPHA Strategic Objective “Strengthen EU Policies to Reduce Health Inequalities and Ensure Universal Access to Sustainable, Inclusive Health Systems”:- Universal and Fair Access to Medicines- Action on Antimicrobial Resistance- Inclusive E- and M-Health- HSPAEach of these areas has operational objectives, milestones, deliverables and impact indicators. The Work Programme 2016 also highlights organisational development objectives, particularly on cooperation with academia, communications and financial sustainability, which are priorities for 2016.
Start date: 01/01/2016 - End date: 31/12/2016
Keywords : [ Amr ] [ Anthrax ] [ Anthrax ] [ Blood ] [ Botulism ] [ Breast ] [ Brucellosis ] [ Campylobacteriosis ] [ Cancer ] [ Cardiovascular Diseases ] [ Cervical ] [ Chlamydia ] [ Cholera ] [ Chronic Diseases ] [ Chronic Diseases ] [ Chronic kidney diseases ] [ Chronic pulmonary diseases ] [ Colorectal ] [ Communicable Diseases ] [ Communicable Diseases ] [ Cryptosporidiosis ] [ Dengue fever ] [ Diabetes ] [ Diphtheria ] [ Diseases of zoonotic and environmental origin and vector borne ] [ E ] [ E/M-Health ] [ Echinococcosis ] [ Economic Policy ] [ Emergent pathogens ] [ Epilepsy ] [ Food and waterborne diseases ] [ Giardisasis ] [ Gonorrhea ] [ HIV, STIs & Blood borne infections ] [ Health Research ] [ Healthcare-associated infections ] [ Hepatitis A ] [ Hepatitis B ] [ Hepatitis C ] [ Hiap ] [ Hiv/Aids ] [ Hpv ] [ Hspa ] [ Hspa. ] [ Influenza ] [ Invasive Haemophilus influenzae disease ] [ Invasive pneumococcal disease ] [ Ischaemic heart disease ] [ Legionnaire's diseaese ] [ Leptospirosis ] [ Leptospirosis ] [ Listeriosis ] [ Lung ] [ M-Health ] [ Malaria ] [ Measles ] [ Menongoccal disease ] [ Multiple sclerosis ] [ Mumps ] [ Musculo skeletal conditions ] [ Ncds ] [ Neurological diseases and disorders ] [ Other specific diseases ] [ Parkinson's disease ] [ Participation ] [ Plague ] [ Polio ] [ Prevention ] [ Prevention ] [ Promotion ] [ Protection ] [ Public Health ] [ Qfever ] [ Rabies ] [ Respiratory tract infections ] [ Rubella ] [ SARS ] [ Salmonellosis ] [ Shigellosis ] [ Shigellosis ] [ Smallpox ] [ Stomach ] [ Stroke ] [ Syphilis ] [ Tetanus ] [ Toxoplasmosis ] [ Trade ] [ Trichinellosis ] [ Tuberculosis ] [ Tularaemia ] [ Tularemia ] [ Type I ] [ Typhoid fever ] [ Universal Access ] [ VTEC ] [ Vaccine-preventable diseases ] [ Variant Creutzfeld-Jakob disease ] [ Viral Haemorrhagic fevers ] [ West Nile fever ] [ Yellow fever ] [ Yersiniosis ] [ campylobacteriosis ] [ pertussis ] [ prostate ] [ salmonellosis ] [ skin ] [ type II ]

Call: Health Programme Adhoc Call for invited (named) beneficiaries
Topic: Vaccine-preventable diseases
Second Programme of Community action in the Field of Health 2008-2013
Promote Vaccinations among Migrant Populations in Europe [PROMOVAX]
Promovax’s general objective is to promote immunizations among migrant populations in Europe, thus contributing to the elimination of vaccine preventable diseases in the region & reducing social ine...
Promovax’s general objective is to promote immunizations among migrant populations in Europe, thus contributing to the elimination of vaccine preventable diseases in the region & reducing social inequalities in health. It aims to complement EU policies on reaching hard-to-reach populations by adding to the knowledge of migrants` immunization barriers, developing educational material for both health professionals & migrants and by developing recommendations for policy-makers.
It aims to:
Identify & record the immunization needs of migrants
Evaluate migrants’ access to immunization in the EU countries
Analyze the legislative context regarding migrant immunizations in the partner countries
Identify & exchange best practices on migrants` immunization health promotion
Enhance health care professionals’ knowledge on immunization needs of migrants and raise cultural sensitivity among health care professionals providing for migrants
Improve migrants’ understanding & acceptance of immunizations and facilitate their access to immunizations by identifying a network of relevant sites.
Start date: 01/05/2010 - End date: 01/05/2013

Call: Improve Citizen''S Health Security (Hs-2009)
Topic: Vaccine-preventable diseases
Second Programme of Community action in the Field of Health 2008-2013
Promotion of Immunization for Health Professionals in Europe [HProImmune]
(1)Increase awareness about the most important vaccine preventable diseases which pose a particular risk to EU HCW (2)Increase awareness about Immunizations among Health Care Workers through a databas...
(1)Increase awareness about the most important vaccine preventable diseases which pose a particular risk to EU HCW (2)Increase awareness about Immunizations among Health Care Workers through a database comprising vaccination specific information from across the EU (3)Provide new knowledge about vaccination behaviors and barriers among HCWs(4)Widely disseminate information on best practices for promoting HCWs immunization in
different health care settings(5)Provide new knowledge on how to communicate and promote immunizations among HCWs by piloting a purpose and tailor-made Immunization Toolkit (6)Increase awareness and promote HCWs immunizations through a widely disseminated and pilot tested HCW Immunization Promotion ToolKit comprising recommendations, communication guidelines, tools and fact sheets
Start date: 01/09/2011 - End date: 01/09/2014

Call: Improve Citizen''S Health Security (Hs-2010)
Topic: Vaccine-preventable diseases
Second Programme of Community action in the Field of Health 2008-2013
FASTVAC: A generic framework for FAST production and evaluation of emergency VACcines [FASTVAC]
The general objective of FastVac is to produce a comprehensive set of predictive rules that will enable accelerated development, evaluation, production & release of emergency vaccines. The "blueprints...
The general objective of FastVac is to produce a comprehensive set of predictive rules that will enable accelerated development, evaluation, production & release of emergency vaccines. The "blueprints" produced will inform the parallel processes of vaccine development & process design, through to phase 1 clinical testing & support for GMP production. By providing evidence-based rules to aid the production of contingency emergency vaccines, FastVac ultimately aims to have a significant effect on the long term health of the human population, both in the EU & internationally. Specific objectives are to develop: evidence-based rules for rapid vaccine design, production & release; & apply principles for vaccine candidate design based on COPs; & apply principles for the use of COPs in vaccine pre-clinical testing & licensure; production principles that will accelerate vaccine production & release; to consolidate a strategic alliance to respond collectively to vaccine-preventable public health emergencies & to build a strategic framework for uptake of novel concepts for vaccine licensure.
Start date: 08/04/2010 - End date: 08/04/2014

Call: Improve Citizen''S Health Security (Hs-2009)
Topic: Vaccine-preventable diseases
Second Programme of Community action in the Field of Health 2008-2013
European Conference on Immunisation Information Systems [ECISS]
To initiate a collaboration on the development and use of IIS (Immunisation Information System) by:
1) Describing uses of IIS, from the perspective of vaccinees, health care providers, e health progr...
To initiate a collaboration on the development and use of IIS (Immunisation Information System) by:
1) Describing uses of IIS, from the perspective of vaccinees, health care providers, e health program developers, public health agencies, regulatory agencies, academic institutions and vaccine manufactures, including use in management of health programs and research
2) Describing the status of IIS in EC
3) Identifying areas were collaboration would be beneficial
4) Proposing objectives and forms for future collaboration
5) Developing a strategy for implementation
6) Forming a network for developing proposals for projects


Start date: 20/03/2010 - End date: 20/03/2011

Call: Improve Citizen''S Health Security (Hs-2009)
Topic: Vaccine-preventable diseases